nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—coronary artery disease—type 2 diabetes mellitus	0.408	0.626	CtDrD
Penbutolol—hypertension—type 2 diabetes mellitus	0.243	0.374	CtDrD
Penbutolol—ORM1—Nateglinide—type 2 diabetes mellitus	0.0733	0.306	CbGbCtD
Penbutolol—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0692	0.288	CbGbCtD
Penbutolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0541	0.226	CbGbCtD
Penbutolol—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0433	0.181	CbGbCtD
Penbutolol—Thrombocytopenic purpura—Glimepiride—type 2 diabetes mellitus	0.00183	0.0271	CcSEcCtD
Penbutolol—Alopecia reversible—Ramipril—type 2 diabetes mellitus	0.00178	0.0264	CcSEcCtD
Penbutolol—Thrombocytopenic purpura—Glyburide—type 2 diabetes mellitus	0.00151	0.0223	CcSEcCtD
Penbutolol—Timolol—ADRB3—type 2 diabetes mellitus	0.000866	0.282	CrCbGaD
Penbutolol—Respiratory distress—Metformin—type 2 diabetes mellitus	0.000837	0.0124	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Linagliptin—type 2 diabetes mellitus	0.0008	0.0118	CcSEcCtD
Penbutolol—Agranulocytosis—Tolbutamide—type 2 diabetes mellitus	0.000795	0.0118	CcSEcCtD
Penbutolol—Respiratory distress—Irbesartan—type 2 diabetes mellitus	0.00079	0.0117	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Nateglinide—type 2 diabetes mellitus	0.000749	0.0111	CcSEcCtD
Penbutolol—Respiratory distress—Losartan—type 2 diabetes mellitus	0.000743	0.011	CcSEcCtD
Penbutolol—Agranulocytosis—Tolazamide—type 2 diabetes mellitus	0.000724	0.0107	CcSEcCtD
Penbutolol—Agranulocytosis—Chlorpropamide—type 2 diabetes mellitus	0.000724	0.0107	CcSEcCtD
Penbutolol—Sweating—Nateglinide—type 2 diabetes mellitus	0.000689	0.0102	CcSEcCtD
Penbutolol—Nadolol—ADRB3—type 2 diabetes mellitus	0.000688	0.224	CrCbGaD
Penbutolol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.000656	0.214	CrCbGaD
Penbutolol—Upper respiratory tract infection—Rosiglitazone—type 2 diabetes mellitus	0.000613	0.00907	CcSEcCtD
Penbutolol—Laryngospasm—Ramipril—type 2 diabetes mellitus	0.000542	0.00803	CcSEcCtD
Penbutolol—Cough—Linagliptin—type 2 diabetes mellitus	0.000523	0.00775	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Pioglitazone—type 2 diabetes mellitus	0.000514	0.00761	CcSEcCtD
Penbutolol—Erectile dysfunction—Pioglitazone—type 2 diabetes mellitus	0.000509	0.00754	CcSEcCtD
Penbutolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.000503	0.164	CrCbGaD
Penbutolol—Upper respiratory tract infection—Sitagliptin—type 2 diabetes mellitus	0.000499	0.00739	CcSEcCtD
Penbutolol—Erectile dysfunction—Sitagliptin—type 2 diabetes mellitus	0.000494	0.00732	CcSEcCtD
Penbutolol—Alopecia—Repaglinide—type 2 diabetes mellitus	0.000493	0.0073	CcSEcCtD
Penbutolol—Sweating—Glipizide—type 2 diabetes mellitus	0.000493	0.0073	CcSEcCtD
Penbutolol—Cough—Nateglinide—type 2 diabetes mellitus	0.00049	0.00725	CcSEcCtD
Penbutolol—Agranulocytosis—Glipizide—type 2 diabetes mellitus	0.00048	0.00711	CcSEcCtD
Penbutolol—Dyspepsia—Tolbutamide—type 2 diabetes mellitus	0.000478	0.00709	CcSEcCtD
Penbutolol—Depression—Sitagliptin—type 2 diabetes mellitus	0.000477	0.00707	CcSEcCtD
Penbutolol—Sweating—Pioglitazone—type 2 diabetes mellitus	0.000472	0.007	CcSEcCtD
Penbutolol—Sweating—Glimepiride—type 2 diabetes mellitus	0.00046	0.00681	CcSEcCtD
Penbutolol—Agranulocytosis—Glimepiride—type 2 diabetes mellitus	0.000448	0.00663	CcSEcCtD
Penbutolol—Hyperhidrosis—Nateglinide—type 2 diabetes mellitus	0.000443	0.00656	CcSEcCtD
Penbutolol—Bradycardia—Glimepiride—type 2 diabetes mellitus	0.000439	0.0065	CcSEcCtD
Penbutolol—Dyspepsia—Tolazamide—type 2 diabetes mellitus	0.000435	0.00645	CcSEcCtD
Penbutolol—Dyspepsia—Chlorpropamide—type 2 diabetes mellitus	0.000435	0.00645	CcSEcCtD
Penbutolol—Fatigue—Tolazamide—type 2 diabetes mellitus	0.000426	0.00631	CcSEcCtD
Penbutolol—Dyspepsia—Acarbose—type 2 diabetes mellitus	0.000418	0.00619	CcSEcCtD
Penbutolol—Diarrhoea—Miglitol—type 2 diabetes mellitus	0.000414	0.00612	CcSEcCtD
Penbutolol—Dyspepsia—Nateglinide—type 2 diabetes mellitus	0.000403	0.00597	CcSEcCtD
Penbutolol—Bradycardia—Bromocriptine—type 2 diabetes mellitus	0.000396	0.00586	CcSEcCtD
Penbutolol—Fatigue—Nateglinide—type 2 diabetes mellitus	0.000395	0.00585	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Gliclazide—type 2 diabetes mellitus	0.000371	0.00549	CcSEcCtD
Penbutolol—Agranulocytosis—Glyburide—type 2 diabetes mellitus	0.000369	0.00547	CcSEcCtD
Penbutolol—Erectile dysfunction—Gliclazide—type 2 diabetes mellitus	0.000367	0.00544	CcSEcCtD
Penbutolol—Nausea—Miglitol—type 2 diabetes mellitus	0.000359	0.00532	CcSEcCtD
Penbutolol—Affect lability—Irbesartan—type 2 diabetes mellitus	0.000359	0.00531	CcSEcCtD
Penbutolol—Asthenia—Tolazamide—type 2 diabetes mellitus	0.000355	0.00525	CcSEcCtD
Penbutolol—Depression—Gliclazide—type 2 diabetes mellitus	0.000354	0.00525	CcSEcCtD
Penbutolol—Dyspepsia—Repaglinide—type 2 diabetes mellitus	0.000349	0.00517	CcSEcCtD
Penbutolol—Mood swings—Irbesartan—type 2 diabetes mellitus	0.000345	0.00511	CcSEcCtD
Penbutolol—Alopecia—Bromocriptine—type 2 diabetes mellitus	0.000344	0.00509	CcSEcCtD
Penbutolol—Sweating—Gliclazide—type 2 diabetes mellitus	0.000341	0.00505	CcSEcCtD
Penbutolol—Headache—Tolbutamide—type 2 diabetes mellitus	0.000341	0.00504	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Valsartan—type 2 diabetes mellitus	0.00034	0.00504	CcSEcCtD
Penbutolol—Diarrhoea—Chlorpropamide—type 2 diabetes mellitus	0.000338	0.00501	CcSEcCtD
Penbutolol—Erectile dysfunction—Valsartan—type 2 diabetes mellitus	0.000337	0.005	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Orlistat—type 2 diabetes mellitus	0.000336	0.00498	CcSEcCtD
Penbutolol—Diarrhoea—Linagliptin—type 2 diabetes mellitus	0.000335	0.00496	CcSEcCtD
Penbutolol—Agranulocytosis—Gliclazide—type 2 diabetes mellitus	0.000332	0.00491	CcSEcCtD
Penbutolol—Asthenia—Nateglinide—type 2 diabetes mellitus	0.000329	0.00487	CcSEcCtD
Penbutolol—Dizziness—Tolazamide—type 2 diabetes mellitus	0.000327	0.00484	CcSEcCtD
Penbutolol—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.000327	0.00484	CcSEcCtD
Penbutolol—Cough—Sitagliptin—type 2 diabetes mellitus	0.000326	0.00483	CcSEcCtD
Penbutolol—Diarrhoea—Acarbose—type 2 diabetes mellitus	0.000325	0.00481	CcSEcCtD
Penbutolol—Bradycardia—Gliclazide—type 2 diabetes mellitus	0.000325	0.00481	CcSEcCtD
Penbutolol—Fatigue—Rosiglitazone—type 2 diabetes mellitus	0.000323	0.00478	CcSEcCtD
Penbutolol—Nausea—Tolbutamide—type 2 diabetes mellitus	0.000323	0.00478	CcSEcCtD
Penbutolol—Depression—Orlistat—type 2 diabetes mellitus	0.000322	0.00477	CcSEcCtD
Penbutolol—Hyperhidrosis—Glipizide—type 2 diabetes mellitus	0.000317	0.0047	CcSEcCtD
Penbutolol—Alopecia—Glyburide—type 2 diabetes mellitus	0.000314	0.00465	CcSEcCtD
Penbutolol—Diarrhoea—Nateglinide—type 2 diabetes mellitus	0.000313	0.00464	CcSEcCtD
Penbutolol—Amnesia—Ramipril—type 2 diabetes mellitus	0.000313	0.00463	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.00031	0.00459	CcSEcCtD
Penbutolol—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00031	0.00459	CcSEcCtD
Penbutolol—Headache—Tolazamide—type 2 diabetes mellitus	0.00031	0.00459	CcSEcCtD
Penbutolol—Headache—Linagliptin—type 2 diabetes mellitus	0.000307	0.00454	CcSEcCtD
Penbutolol—Hyperhidrosis—Pioglitazone—type 2 diabetes mellitus	0.000304	0.0045	CcSEcCtD
Penbutolol—Dizziness—Nateglinide—type 2 diabetes mellitus	0.000303	0.00449	CcSEcCtD
Penbutolol—Insomnia—Glipizide—type 2 diabetes mellitus	0.000297	0.00439	CcSEcCtD
Penbutolol—Hyperhidrosis—Glimepiride—type 2 diabetes mellitus	0.000296	0.00438	CcSEcCtD
Penbutolol—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.000294	0.00435	CcSEcCtD
Penbutolol—Nausea—Tolazamide—type 2 diabetes mellitus	0.000294	0.00435	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.000293	0.00433	CcSEcCtD
Penbutolol—Dyspnoea—Glipizide—type 2 diabetes mellitus	0.000293	0.00433	CcSEcCtD
Penbutolol—Dyspepsia—Glipizide—type 2 diabetes mellitus	0.000289	0.00428	CcSEcCtD
Penbutolol—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.000284	0.00421	CcSEcCtD
Penbutolol—Nausea—Acarbose—type 2 diabetes mellitus	0.000282	0.00418	CcSEcCtD
Penbutolol—Pain—Glipizide—type 2 diabetes mellitus	0.000281	0.00415	CcSEcCtD
Penbutolol—Dyspnoea—Pioglitazone—type 2 diabetes mellitus	0.00028	0.00415	CcSEcCtD
Penbutolol—Insomnia—Glimepiride—type 2 diabetes mellitus	0.000277	0.0041	CcSEcCtD
Penbutolol—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.000276	0.00409	CcSEcCtD
Penbutolol—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000275	0.00408	CcSEcCtD
Penbutolol—Dyspnoea—Glimepiride—type 2 diabetes mellitus	0.000273	0.00404	CcSEcCtD
Penbutolol—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.000273	0.00404	CcSEcCtD
Penbutolol—Nausea—Nateglinide—type 2 diabetes mellitus	0.000272	0.00403	CcSEcCtD
Penbutolol—Bradycardia—Metformin—type 2 diabetes mellitus	0.000272	0.00402	CcSEcCtD
Penbutolol—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000271	0.00402	CcSEcCtD
Penbutolol—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000271	0.00401	CcSEcCtD
Penbutolol—Dyspepsia—Glimepiride—type 2 diabetes mellitus	0.00027	0.00399	CcSEcCtD
Penbutolol—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00398	CcSEcCtD
Penbutolol—Dyspepsia—Sitagliptin—type 2 diabetes mellitus	0.000269	0.00398	CcSEcCtD
Penbutolol—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000264	0.00391	CcSEcCtD
Penbutolol—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000263	0.0039	CcSEcCtD
Penbutolol—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000262	0.00388	CcSEcCtD
Penbutolol—Pain—Sitagliptin—type 2 diabetes mellitus	0.000261	0.00386	CcSEcCtD
Penbutolol—Alopecia—Valsartan—type 2 diabetes mellitus	0.000259	0.00384	CcSEcCtD
Penbutolol—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000257	0.0038	CcSEcCtD
Penbutolol—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000256	0.0038	CcSEcCtD
Penbutolol—Alopecia—Orlistat—type 2 diabetes mellitus	0.000256	0.00379	CcSEcCtD
Penbutolol—Sweating—Losartan—type 2 diabetes mellitus	0.000253	0.00375	CcSEcCtD
Penbutolol—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.00025	0.0037	CcSEcCtD
Penbutolol—Headache—Repaglinide—type 2 diabetes mellitus	0.000248	0.00368	CcSEcCtD
Penbutolol—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000248	0.00367	CcSEcCtD
Penbutolol—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000247	0.00365	CcSEcCtD
Penbutolol—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000246	0.00365	CcSEcCtD
Penbutolol—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000244	0.00361	CcSEcCtD
Penbutolol—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000243	0.0036	CcSEcCtD
Penbutolol—Cough—Gliclazide—type 2 diabetes mellitus	0.000242	0.00359	CcSEcCtD
Penbutolol—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000238	0.00353	CcSEcCtD
Penbutolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000236	0.0768	CrCbGaD
Penbutolol—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000236	0.0035	CcSEcCtD
Penbutolol—Nausea—Repaglinide—type 2 diabetes mellitus	0.000236	0.00349	CcSEcCtD
Penbutolol—Asthenia—Glipizide—type 2 diabetes mellitus	0.000235	0.00349	CcSEcCtD
Penbutolol—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000235	0.00348	CcSEcCtD
Penbutolol—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000234	0.00346	CcSEcCtD
Penbutolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000226	0.00334	CcSEcCtD
Penbutolol—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000225	0.00333	CcSEcCtD
Penbutolol—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000224	0.00332	CcSEcCtD
Penbutolol—Cough—Valsartan—type 2 diabetes mellitus	0.000223	0.0033	CcSEcCtD
Penbutolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000223	0.0033	CcSEcCtD
Penbutolol—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000222	0.00329	CcSEcCtD
Penbutolol—Cough—Orlistat—type 2 diabetes mellitus	0.00022	0.00326	CcSEcCtD
Penbutolol—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00022	0.00325	CcSEcCtD
Penbutolol—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000219	0.00325	CcSEcCtD
Penbutolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000219	0.00324	CcSEcCtD
Penbutolol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00323	CcSEcCtD
Penbutolol—Sweating—Ramipril—type 2 diabetes mellitus	0.000217	0.00322	CcSEcCtD
Penbutolol—Dizziness—Glipizide—type 2 diabetes mellitus	0.000217	0.00321	CcSEcCtD
Penbutolol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000215	0.00318	CcSEcCtD
Penbutolol—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000211	0.00313	CcSEcCtD
Penbutolol—Alopecia—Losartan—type 2 diabetes mellitus	0.00021	0.0031	CcSEcCtD
Penbutolol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000209	0.0031	CcSEcCtD
Penbutolol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000209	0.00309	CcSEcCtD
Penbutolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000208	0.00308	CcSEcCtD
Penbutolol—Headache—Glipizide—type 2 diabetes mellitus	0.000206	0.00304	CcSEcCtD
Penbutolol—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000205	0.00304	CcSEcCtD
Penbutolol—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000202	0.003	CcSEcCtD
Penbutolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000202	0.00299	CcSEcCtD
Penbutolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000202	0.00299	CcSEcCtD
Penbutolol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.0002	0.00296	CcSEcCtD
Penbutolol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000199	0.00295	CcSEcCtD
Penbutolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00293	CcSEcCtD
Penbutolol—Headache—Pioglitazone—type 2 diabetes mellitus	0.000197	0.00292	CcSEcCtD
Penbutolol—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000195	0.00289	CcSEcCtD
Penbutolol—Nausea—Glipizide—type 2 diabetes mellitus	0.000195	0.00289	CcSEcCtD
Penbutolol—Pain—Gliclazide—type 2 diabetes mellitus	0.000194	0.00287	CcSEcCtD
Penbutolol—Headache—Glimepiride—type 2 diabetes mellitus	0.000192	0.00284	CcSEcCtD
Penbutolol—Cough—Irbesartan—type 2 diabetes mellitus	0.000191	0.00283	CcSEcCtD
Penbutolol—Headache—Sitagliptin—type 2 diabetes mellitus	0.000191	0.00283	CcSEcCtD
Penbutolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000189	0.0028	CcSEcCtD
Penbutolol—Insomnia—Valsartan—type 2 diabetes mellitus	0.000188	0.00279	CcSEcCtD
Penbutolol—Insomnia—Orlistat—type 2 diabetes mellitus	0.000186	0.00276	CcSEcCtD
Penbutolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000186	0.00275	CcSEcCtD
Penbutolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000183	0.00272	CcSEcCtD
Penbutolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000183	0.00272	CcSEcCtD
Penbutolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000183	0.0027	CcSEcCtD
Penbutolol—Nausea—Glimepiride—type 2 diabetes mellitus	0.000182	0.00269	CcSEcCtD
Penbutolol—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000181	0.00268	CcSEcCtD
Penbutolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000181	0.00268	CcSEcCtD
Penbutolol—Asthenia—Glyburide—type 2 diabetes mellitus	0.000181	0.00268	CcSEcCtD
Penbutolol—Cough—Losartan—type 2 diabetes mellitus	0.00018	0.00267	CcSEcCtD
Penbutolol—Alopecia—Ramipril—type 2 diabetes mellitus	0.00018	0.00266	CcSEcCtD
Penbutolol—Fatigue—Valsartan—type 2 diabetes mellitus	0.00018	0.00266	CcSEcCtD
Penbutolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000179	0.00265	CcSEcCtD
Penbutolol—Fatigue—Orlistat—type 2 diabetes mellitus	0.000177	0.00263	CcSEcCtD
Penbutolol—Pain—Orlistat—type 2 diabetes mellitus	0.000176	0.00261	CcSEcCtD
Penbutolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000173	0.00256	CcSEcCtD
Penbutolol—Headache—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00256	CcSEcCtD
Penbutolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000173	0.00256	CcSEcCtD
Penbutolol—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000169	0.0025	CcSEcCtD
Penbutolol—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000167	0.00247	CcSEcCtD
Penbutolol—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000164	0.00243	CcSEcCtD
Penbutolol—Fatigue—Metformin—type 2 diabetes mellitus	0.000164	0.00242	CcSEcCtD
Penbutolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000163	0.00241	CcSEcCtD
Penbutolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000163	0.00241	CcSEcCtD
Penbutolol—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000163	0.00241	CcSEcCtD
Penbutolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.00016	0.00236	CcSEcCtD
Penbutolol—Headache—Glyburide—type 2 diabetes mellitus	0.000158	0.00234	CcSEcCtD
Penbutolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000158	0.00233	CcSEcCtD
Penbutolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000155	0.0023	CcSEcCtD
Penbutolol—Cough—Ramipril—type 2 diabetes mellitus	0.000154	0.00229	CcSEcCtD
Penbutolol—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000154	0.00229	CcSEcCtD
Penbutolol—Pain—Irbesartan—type 2 diabetes mellitus	0.000153	0.00227	CcSEcCtD
Penbutolol—Insomnia—Losartan—type 2 diabetes mellitus	0.000152	0.00226	CcSEcCtD
Penbutolol—Dyspnoea—Losartan—type 2 diabetes mellitus	0.00015	0.00222	CcSEcCtD
Penbutolol—Nausea—Glyburide—type 2 diabetes mellitus	0.00015	0.00222	CcSEcCtD
Penbutolol—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00015	0.00222	CcSEcCtD
Penbutolol—Asthenia—Valsartan—type 2 diabetes mellitus	0.000149	0.00221	CcSEcCtD
Penbutolol—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000148	0.0022	CcSEcCtD
Penbutolol—Asthenia—Orlistat—type 2 diabetes mellitus	0.000148	0.00219	CcSEcCtD
Penbutolol—Fatigue—Losartan—type 2 diabetes mellitus	0.000145	0.00215	CcSEcCtD
Penbutolol—Pain—Losartan—type 2 diabetes mellitus	0.000144	0.00213	CcSEcCtD
Penbutolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000143	0.00211	CcSEcCtD
Penbutolol—Headache—Gliclazide—type 2 diabetes mellitus	0.000142	0.0021	CcSEcCtD
Penbutolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000142	0.0021	CcSEcCtD
Penbutolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000141	0.00209	CcSEcCtD
Penbutolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00014	0.00207	CcSEcCtD
Penbutolol—Dizziness—Valsartan—type 2 diabetes mellitus	0.000138	0.00204	CcSEcCtD
Penbutolol—Dizziness—Orlistat—type 2 diabetes mellitus	0.000136	0.00202	CcSEcCtD
Penbutolol—Asthenia—Metformin—type 2 diabetes mellitus	0.000136	0.00202	CcSEcCtD
Penbutolol—Nausea—Gliclazide—type 2 diabetes mellitus	0.000135	0.00199	CcSEcCtD
Penbutolol—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000133	0.00197	CcSEcCtD
Penbutolol—Insomnia—Ramipril—type 2 diabetes mellitus	0.000131	0.00193	CcSEcCtD
Penbutolol—Headache—Valsartan—type 2 diabetes mellitus	0.00013	0.00193	CcSEcCtD
Penbutolol—Diarrhoea—Metformin—type 2 diabetes mellitus	0.00013	0.00192	CcSEcCtD
Penbutolol—Headache—Orlistat—type 2 diabetes mellitus	0.000129	0.00191	CcSEcCtD
Penbutolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000129	0.00191	CcSEcCtD
Penbutolol—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000128	0.0019	CcSEcCtD
Penbutolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000127	0.00188	CcSEcCtD
Penbutolol—Dizziness—Metformin—type 2 diabetes mellitus	0.000125	0.00186	CcSEcCtD
Penbutolol—Fatigue—Ramipril—type 2 diabetes mellitus	0.000125	0.00184	CcSEcCtD
Penbutolol—Nausea—Valsartan—type 2 diabetes mellitus	0.000124	0.00183	CcSEcCtD
Penbutolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000122	0.00181	CcSEcCtD
Penbutolol—Nausea—Orlistat—type 2 diabetes mellitus	0.000122	0.00181	CcSEcCtD
Penbutolol—Asthenia—Losartan—type 2 diabetes mellitus	0.000121	0.00179	CcSEcCtD
Penbutolol—Headache—Metformin—type 2 diabetes mellitus	0.000119	0.00176	CcSEcCtD
Penbutolol—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000118	0.00175	CcSEcCtD
Penbutolol—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000115	0.00171	CcSEcCtD
Penbutolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000114	0.00169	CcSEcCtD
Penbutolol—Nausea—Metformin—type 2 diabetes mellitus	0.000113	0.00167	CcSEcCtD
Penbutolol—Headache—Irbesartan—type 2 diabetes mellitus	0.000112	0.00166	CcSEcCtD
Penbutolol—Dizziness—Losartan—type 2 diabetes mellitus	0.000111	0.00165	CcSEcCtD
Penbutolol—Nausea—Irbesartan—type 2 diabetes mellitus	0.000106	0.00157	CcSEcCtD
Penbutolol—Headache—Losartan—type 2 diabetes mellitus	0.000106	0.00156	CcSEcCtD
Penbutolol—Asthenia—Ramipril—type 2 diabetes mellitus	0.000104	0.00153	CcSEcCtD
Penbutolol—Nausea—Losartan—type 2 diabetes mellitus	0.0001	0.00148	CcSEcCtD
Penbutolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.88e-05	0.00146	CcSEcCtD
Penbutolol—Dizziness—Ramipril—type 2 diabetes mellitus	9.55e-05	0.00141	CcSEcCtD
Penbutolol—Headache—Ramipril—type 2 diabetes mellitus	9.05e-05	0.00134	CcSEcCtD
Penbutolol—Nausea—Ramipril—type 2 diabetes mellitus	8.58e-05	0.00127	CcSEcCtD
Penbutolol—Propranolol—CYP1A2—type 2 diabetes mellitus	7.42e-05	0.0242	CrCbGaD
Penbutolol—Propranolol—CYP3A4—type 2 diabetes mellitus	4.91e-05	0.016	CrCbGaD
Penbutolol—HTR1A—Signaling by GPCR—CCR5—type 2 diabetes mellitus	9.19e-06	0.000237	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—C3—type 2 diabetes mellitus	9.19e-06	0.000237	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	9.12e-06	0.000235	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	9.08e-06	0.000234	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT2—type 2 diabetes mellitus	9.06e-06	0.000234	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	9.06e-06	0.000233	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	9.06e-06	0.000233	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	9.06e-06	0.000233	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—C3—type 2 diabetes mellitus	8.98e-06	0.000232	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.92e-06	0.00023	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.92e-06	0.00023	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.88e-06	0.000229	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.86e-06	0.000228	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.86e-06	0.000228	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.81e-06	0.000227	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.77e-06	0.000226	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.77e-06	0.000226	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.73e-06	0.000225	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.68e-06	0.000224	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.66e-06	0.000223	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.66e-06	0.000223	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.62e-06	0.000222	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.62e-06	0.000222	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.58e-06	0.000221	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.58e-06	0.000221	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.58e-06	0.000221	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.58e-06	0.000221	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	8.58e-06	0.000221	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.53e-06	0.00022	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GNB3—type 2 diabetes mellitus	8.5e-06	0.000219	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.48e-06	0.000219	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.43e-06	0.000217	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.43e-06	0.000217	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.4e-06	0.000216	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.4e-06	0.000216	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CALM1—type 2 diabetes mellitus	8.39e-06	0.000216	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.39e-06	0.000216	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AVP—type 2 diabetes mellitus	8.38e-06	0.000216	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	8.38e-06	0.000216	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	8.35e-06	0.000215	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	8.31e-06	0.000214	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.29e-06	0.000214	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	8.25e-06	0.000213	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.24e-06	0.000212	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	8.22e-06	0.000212	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	8.21e-06	0.000212	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	8.21e-06	0.000212	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	8.11e-06	0.000209	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	8.1e-06	0.000209	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	8.07e-06	0.000208	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	8.06e-06	0.000208	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.99e-06	0.000206	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	7.97e-06	0.000206	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.95e-06	0.000205	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.89e-06	0.000203	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.85e-06	0.000202	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GCG—type 2 diabetes mellitus	7.85e-06	0.000202	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.81e-06	0.000201	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.78e-06	0.0002	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	7.74e-06	0.000199	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.72e-06	0.000199	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.7e-06	0.000198	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.68e-06	0.000198	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GCG—type 2 diabetes mellitus	7.68e-06	0.000198	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.64e-06	0.000197	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.6e-06	0.000196	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	7.57e-06	0.000195	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.56e-06	0.000195	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.53e-06	0.000194	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	7.51e-06	0.000194	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.51e-06	0.000194	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.39e-06	0.00019	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.37e-06	0.00019	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.35e-06	0.000189	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	7.26e-06	0.000187	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.22e-06	0.000186	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.21e-06	0.000186	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.19e-06	0.000185	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	7.13e-06	0.000184	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	7.06e-06	0.000182	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	7.06e-06	0.000182	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	7.03e-06	0.000181	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	6.97e-06	0.00018	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.9e-06	0.000178	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.9e-06	0.000178	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.83e-06	0.000176	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.77e-06	0.000174	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.68e-06	0.000172	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.68e-06	0.000172	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.68e-06	0.000172	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.65e-06	0.000171	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	6.64e-06	0.000171	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	6.63e-06	0.000171	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.62e-06	0.000171	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	6.62e-06	0.000171	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.62e-06	0.000171	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.55e-06	0.000169	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.53e-06	0.000168	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.53e-06	0.000168	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.53e-06	0.000168	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	6.51e-06	0.000168	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.5e-06	0.000168	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	6.48e-06	0.000167	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	6.48e-06	0.000167	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.47e-06	0.000167	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.47e-06	0.000167	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	6.45e-06	0.000166	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.43e-06	0.000166	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.41e-06	0.000165	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.41e-06	0.000165	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	6.39e-06	0.000165	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.39e-06	0.000165	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.36e-06	0.000164	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.35e-06	0.000164	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.33e-06	0.000163	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	6.31e-06	0.000163	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.29e-06	0.000162	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	6.26e-06	0.000161	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.21e-06	0.00016	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	6.17e-06	0.000159	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	6.16e-06	0.000159	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	6.15e-06	0.000158	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.12e-06	0.000158	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	6.07e-06	0.000157	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	6.03e-06	0.000155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	6.03e-06	0.000155	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.9e-06	0.000152	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	5.89e-06	0.000152	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	5.78e-06	0.000149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.78e-06	0.000149	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.77e-06	0.000149	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.68e-06	0.000146	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.65e-06	0.000146	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.55e-06	0.000143	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	5.55e-06	0.000143	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	5.54e-06	0.000143	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.53e-06	0.000143	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.45e-06	0.00014	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.43e-06	0.00014	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	5.43e-06	0.00014	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.36e-06	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.35e-06	0.000138	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.33e-06	0.000137	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	5.31e-06	0.000137	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.29e-06	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.28e-06	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	5.27e-06	0.000136	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.18e-06	0.000134	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.18e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	5.16e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	5.16e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.16e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	5.16e-06	0.000133	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	5.11e-06	0.000132	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.09e-06	0.000131	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	5.07e-06	0.000131	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	5.06e-06	0.00013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	5.05e-06	0.00013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	5.05e-06	0.00013	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	5.05e-06	0.00013	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	5.04e-06	0.00013	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.99e-06	0.000129	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.96e-06	0.000128	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.94e-06	0.000127	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.94e-06	0.000127	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.88e-06	0.000126	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.87e-06	0.000126	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.86e-06	0.000125	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.86e-06	0.000125	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.76e-06	0.000123	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.66e-06	0.00012	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.61e-06	0.000119	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	4.57e-06	0.000118	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.51e-06	0.000116	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	4.41e-06	0.000114	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.41e-06	0.000114	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.34e-06	0.000112	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	4.32e-06	0.000111	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.27e-06	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.26e-06	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.25e-06	0.000109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.25e-06	0.000109	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	4.22e-06	0.000109	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.17e-06	0.000108	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.17e-06	0.000108	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.16e-06	0.000107	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.15e-06	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.15e-06	0.000107	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.12e-06	0.000106	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.1e-06	0.000106	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.08e-06	0.000105	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.08e-06	0.000105	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.06e-06	0.000105	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.05e-06	0.000104	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.96e-06	0.000102	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.9e-06	0.0001	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.88e-06	9.99e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.87e-06	9.97e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.87e-06	9.97e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.86e-06	9.94e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.78e-06	9.76e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.78e-06	9.76e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.78e-06	9.74e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.7e-06	9.54e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.7e-06	9.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.64e-06	9.39e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	3.59e-06	9.26e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.56e-06	9.18e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.5e-06	9.02e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.48e-06	8.98e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.32e-06	8.55e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.28e-06	8.47e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.26e-06	8.41e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.24e-06	8.36e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.21e-06	8.28e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.21e-06	8.28e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.19e-06	8.23e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.17e-06	8.17e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.15e-06	8.12e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.14e-06	8.1e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.12e-06	8.05e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.1e-06	8e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.07e-06	7.92e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.04e-06	7.83e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.01e-06	7.76e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3e-06	7.74e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.97e-06	7.65e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.95e-06	7.59e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.94e-06	7.57e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.88e-06	7.42e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.86e-06	7.38e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.8e-06	7.22e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.79e-06	7.18e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.74e-06	7.06e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.73e-06	7.03e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.67e-06	6.87e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.56e-06	6.59e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.51e-06	6.47e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.5e-06	6.45e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.45e-06	6.32e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.45e-06	6.31e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.42e-06	6.24e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.4e-06	6.18e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.23e-06	5.76e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.93e-06	4.97e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.89e-06	4.86e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.84e-06	4.75e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.78e-06	4.58e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.74e-06	4.48e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.7e-06	4.38e-05	CbGpPWpGaD
